Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Dec 27;17(12):e0279518. doi: 10.1371/journal.pone.0279518

The impact of surgeon’s experience and sex on the incidence of cystoid macular edema after uneventful cataract surgery

Wolfgang List 1,*, Gernot Steinwender 1, Wilfried Glatz 1, Regina Riedl 2, Andreas Wedrich 1, Domagoj Ivastinovic 1
Editor: Andrzej Grzybowski3
PMCID: PMC9794095  PMID: 36574394

Abstract

Purpose

To assess the rate of pseudophakic cystoid macular edema (pCME) in uneventful cataract surgery in surgeons in training vs experienced surgeons and to analyze the rate of pCME according to surgeon’s sex.

Methods

Medical reports post phacoemulsification between 2010 and 2018 at the Department of Ophthalmology, Medical University of Graz, Austria, were reviewed for pCME. A running lifetime number of preceding cataract surgeries was used to express hands-on experience. A cut-off number of 300 surgeries was defined to distinguish between surgeons in training and experienced surgeons. Outcome parameters were incidence of pCME, patient’s sex and age, laterality of eye, coexistence of pseudoexfoliation syndrome (PEX), duration of surgery and surgeon’s sex.

Results

25.422 surgeries on 18.266 patients were included. The majority was performed by experienced surgeons (23.139, 91.0%) vs 2.283 (9.0%) by surgeons in training (25 surgeons, 9 (36%) female and 16 (64%) male). pCME occurred in 32 eyes (1.4%) following surgery by surgeons in training and in 152 eyes (0.7%) following surgery by experienced surgeons. Chance for pCME was 1.57 higher in training surgeries (95% CI 1.03–2.41, p = 0.034) and longer duration (OR = 1.04; 95% CI 1.02–1.07, p = 0.001). After excluding the first 100 surgeries for every surgeon in training similar results were observed. No difference in risk for pCME was found between female and male surgeons in both groups (training and experienced surgeons).

Conclusion

In conclusion, the rate for pCME after uneventful cataract surgery is significantly higher for surgeons in training but steadily decreasing and associated to surgical time. No difference in the risk for pCME was found between female and male surgeons.

Introduction

Pseudophakic cystoid macular edema (pCME), also referred to as Irvine-Gass syndrome, was reported to occur in 0.2% to 2.35% after uncomplicated cataract surgery [14]. Due to the regular use of spectral domain optical coherence tomography (sdOCT) pCME appeared to be much more frequent, reaching up to 13.9% in recent years [2, 58]. The exact pathomechanisms of pCME are not yet fully understood, however, there are three main components assumed: breakdown of the blood-retina-barrier, intraocular inflammation with an increased release of proteins and prostaglandins into the intraocular milieu and mechanically induced forces on the vitreous. Appearance of these can be deduced to a more traumatic surgery and prolonged surgery duration–features that are likely to apply to surgeries performed by surgeons in training [918].

In previous years, a recommendation of 40 to 80 procedures was mentioned to achieve proficient surgery with low rates of complications [1923]. In contrast, after analysis of the risk for posterior capsule rupture the German Ophthalmological Society (GOS) proposed that the first 300 cataract surgeries should be performed under supervision [24]. According to this proposal, we set the cut-off for surgeons in training versus experienced surgeons in our analysis to 300.

The association between complicated cataract surgery and appearance of pCME is already known [2528]. Following posterior capsule rupture, the relative risk (RR) for pCME increases significantly by RR 2.61 to 5.05 [25, 29]. We therefore only included uneventful cataract surgeries to assess the rate of pCME in uneventful cataract surgery.

In the present study we assessed the rate of pCME in surgeons in training vs experienced surgeons in uneventful cataract surgery and analyzed the rate of pCME according to surgeon’s sex.

Materials and methods

In this retrospective study, we reviewed all uneventful phacoemulsifications with intraocular lens (IOL) implantations at the Department of Ophthalmology, Medical University of Graz, between January 1st, 2010 and September 30th, 2018. During this study period, we carefully assessed all diagnosed clinically significant pCME in the postoperative course. A continuously running lifetime number of total preceding cataract surgeries for each surgeon was used to express their surgical hands-on experience. The counting began with the first cataract surgery performed, independent from the time period of this study. Surgeons who worked and operated on in other hospitals before were asked for the number of previously conducted cataract surgeries. Surgeries that were performed outside of our hospital remained unconsidered for this analysis. Altogether we accessed data from 25 cataract surgeons from our department during the study period.

Surgical and medical reports were thoroughly reviewed for presence of the following exclusion criteria: posterior capsule ruptures with and without vitreous body prolapses, zonular dialysis, iris trauma or intraoperative iris manipulation, intraocular hemorrhage during surgery, IOL implantation in aphakic eyes, combined procedures (IOL implantation with simultaneous glaucoma surgery or simultaneous vitrectomy), diabetes mellitus, prior retinal vein occlusions, history of uveitis and iritis, maculopathies and retinopathies of any kind and exudative macular degenerations, epiretinal membranes, presence of ocular tumors, implausible surgery documentation (surgery duration less than 3 minutes), as well as previous ophthalmic surgeries within the last three months. Data remained unconsidered if one or more was applicable. Only uneventful surgeries were considered. We therefore excluded all surgeries from analysis for the above-mentioned exclusion criteria, as well as surgeries with a duration of over 30 minutes (duration between the beginning of the surgery until the end of the surgery). Only patients with clinically significant CME were considered for this study if they were referred by registered ophthalmologists or diagnosed at the outpatient department.

This single-center study was conducted at the Department of Ophthalmology, Medical University of Graz. Ethics Committee approval was obtained by the Ethics Committee of the Medical University of Graz (approval number: 30–413 ex 17/18). The Ethics Committee of the Medical University of Graz ruled that written informed consent was not required for this study. Patient records were anonymised and de-identified prior to analysis. The study was conducted in accordance with the principles and regulations of the Declaration of Helsinki. Data was accessible for members of the project team solely.

Study sample

A total of 33.319 cataract surgeries were performed during the study period. In consideration of inclusion and exclusion criteria, 25.422 surgeries from 18.266 patients were included in our analyses. The majority of surgeries was performed by experienced surgeons (23.139, 91.0%) while 2.283 (9.0%) surgeries were performed by surgeons in training. Data of 25 surgeons were included, 9 (36%) females and 16 (64%) males.

Surgical training

Two groups were defined distinguishing between surgeons in training and experienced surgeons. The cut-off for surgeons in training was set for the first 300 surgeries. This cut-off was chosen according to the proposal of the German Ophthalmological Society (GOS), recommending the procedure of the first 300 cataract surgeries under supervision.

In addition, we also performed analysis excluding the first 100 surgeries as surgeons usually start off by performing only a few steps. Surgeons in training are generally assigned to and supervised by one or two experienced ophthalmic surgeons at all stages of training. The teaching strategy is determined by the experienced surgeon: first surgeries are either done step by step so that surgeons in training can start off by doing the incisions and capsulorhexis or by aspiration of the viscoelastics at the end of the surgery. Supervision is gradually eased by experienced surgeons as routine is gained.

Surgical technique

All cataract surgeries were performed using small incision phacoemulsification technique and implantation of posterior chamber intraocular lenses. A local anesthesia was obtained by parabulbar injection of Oxybuprocain 0.4%, 2.5ml Ropivacain 10mg/ml + 2.5ml Lidocain 2%. Before corneal incision, povidone iodine 2% was instilled onto the cornea and conjunctiva. Intraoperative mydriasis was obtained by topical instillation of tropicamide 0.5% and phenylephrine 1.0% twice preoperatively and intracameral injection of adrenaline and lidocaine before capsulorhexis. The anterior chamber was stabilized by injection of methyl cellulose, capsulorhexis was performed with a needle.

Postoperative standardized therapeutic regimen in the study period consisted of glucocorticoid and antibiotic eye drops and ointment. A combination of betamethasone and neomycin sulfate eye drops (Betnesol N®, ALFASIGMA S.P.A., Italy; Betamethasone 1mg/ml, Neomycin sulfate 5mg/ml) was prescribed 5 times per day and tapered by one drop every week. For the first postoperative week, a combination of dexamethasone and gentamicin sulfate ointment at nighttime was additionally prescribed (Dexagenta®, Ursapharm GmbH, Austria; Dexamethasone 0.3mg/g, Gentamicin sulfate 5mg/g).

Pseudophakic cystoid macular edema

Every pCME was related to a surgeon in training or an experienced surgeon, according to the surgeon’s running lifetime number of preceding cataract surgeries. In the course of the study, surgeons could advance from surgeons in training to experienced surgeons if they exceeded the 300 previous procedures.

pCME was defined as macular thickness over 300 μm and the presence of intraretinal hyporeflective cysts within the ETDRS (Early Treatment Diabetic Retinopathy Study) circle (central, concentric parafoveal area, 6.0 mm) [2, 8, 30]. Therefore, sdOCT (Spectralis version 6.0.9 software, Heidelberg Engineering, Heidelberg, Germany) was used with following adjustments: volumetric scanning with 25 sections covering a field of 20x20° in the macular region. A bandwidth of 297 nm and a wavelength of 815 nm was used [31, 32]. Eye movement was compensated using the eye tracking software (TruTrack) to remain exact positioning of the recorded scans [31]. The scanning was done using high-speed mode with a resolution of 7 μm axially and 14μm laterally, the in between distance for every section was set to 240 μm [32].

In addition to pCME, we additionally analyzed covariables including patient’s sex and age, side of the eye, coexistence of pseudo exfoliation syndrome (PEX), the duration of the surgery and surgeon’s sex.

Statistical analysis

In descriptive statistics, continuous parameters are presented as median, minimum and maximum and categorical parameters as frequencies and percent. To evaluate the influence of surgeries with surgeons in training and experienced surgeons on occurrence of pCME, generalized estimating equations (GEE) with logit as link function and exchangeable working correlation structure accounting for repeated surgeries on the same patient was used [33]. The multivariable model includes pCME as dependent parameter and the surgeon’s training state (surgeon in training or experienced), patient’s sex (female/male), eye (left/right), coexistence of pseudo exfoliation syndrome (PEX: yes/no), patients age and duration (in minutes) of the procedure as independent parameters. The results are presented as odds ratios (ORs) with their corresponding 95% confidence interval (CI) and p-value. In sensitivity analyses, the model was repeated, but excluding the first 100 surgeries to rule out the influence of intervening supervision. In addition, a model, including the surgeon’s sex as an additional parameter was performed. For visualization purposes of a learning curve, a B-spline fit with 3 knots was performed by plotting pCME occurrence against the number of surgeon’s previous cataract operations. Statistical analyses were performed using SAS 9.4 (SAS Institute, Cary NC).

Results

Characteristics of our study population in total and by training and experienced surgeries are summarized in Table 1.

Table 1. Characteristics of the study population in total and by surgeon in training and experienced surgeon.

Characteristic Description Total N = 25.422 Surgeon in training N = 2.283 Experienced Surgeon N = 23.139 p-value*
Age (in years) 76.0 (50.0, 100.0) 77.0 (50.0, 97.0) 76.0 (50.0, 100.0) < .001
Duration of Surgery (in min) (in minutes) 11.1 (3.0, 30.0) 17.2 (5.9, 30.0) 10.8 (3.0, 30.0) < .001
Patient’s sex Female 15539 (61.1%) 1417 (62.1%) 14122 (61.0%) 0.337
Male 9883 (38.9%) 866 (37.9%) 9017 (39.0%)
Side LE 12569 (49.5%) 1188 (52.0%) 11381 (49.2%) 0.005
RE 12849 (50.6%) 1195 (48.0%) 11754 (50.8%)
Missing 4 4
PEX PEX 1953 (7.7%) 113 (4.9%) 1840 (8.0%) < .001
No PEX 23468 (92.3%) 2170 (95.1%) 21298 (92.0%)
Missing 1 1
pCME pCME 184 (0.7%) 32 (1.4%) 152 (0.7%) -
No pCME 25238 (99.3%) 2251 (98.6%) 22987 (99.3%)

Abbreviations: LE: left eye, min: minute, N: absolute number, pCME: pseudophakic cystoid macular edema, PEX: pseudo exfoliation syndrome, RE: right eye.

*p-value from generalized estimating equations model

In training surgeries vs experienced surgeries, patients were older (median 77 (50–97) vs 76 (50–100) years), the duration of the surgery was longer (median 17.2 (5.9–30) vs 10.8 (3–30) minutes), patients were more commonly female (62.1% vs 61.0%), more left eyes were operated on (52.0% vs. 49.2%) and PEX was seen in 4.9% of eyes, compared to 8.0% in surgeries by experienced surgeons. In total, pCME was reported in 184 eyes (0.7%) after surgery, thereof in 32 eyes (1.4%) operated by surgeons in training and 152 eyes (0.7%) operated by experienced surgeons.

In multivariable analysis, 52 surgeries were excluded due to missing values. The results are presented in Table 2. We observed a higher risk for pCME for surgeons in training (OR = 1.57; 95% CI 1.03–2.40, p = 0.034) and longer duration (OR = 1.04; 95% CI 1.02–1.07, p = 0.001). Lower chances were observed for surgeries on left eyes (OR = 0.74; 95% CI 0.57–0.96, p = 0.022) and by trend for female patients (OR = 0.77; 95% CI 0.56–1.06, p = 0.108). Including only first eyes in patients with bilateral cataract surgery yields similar results. There was no difference in the risk for pCME between learning surgeries and experienced surgeries focusing on eyes with PEX, patient’s age and surgeon’s sex. After excluding the first 100 surgeries for every surgeon in training similar results were observed (S1 Table).

Table 2. Results for multivariable logistic regression (generalized estimating equations model).

pCME No pCME OR 95% CI p-value
OR Surgeon in training vs Experienced surgeon 32 (17.4%) 2251 (8.9%) 1.58 1.03 2.10 0.034
152 (82.6%) 22987 (91.1%) Reference
OR F vs M 103 (56.0%) 15436 (61.2%) 0.77 0.56 1.06 0.108
81 (44.0%) 9802 (38.8%) Reference
OR LE vs RE 78 (42.4%) 12491 (49.5%) 0.74 0.57 0.96 0.022
106 (57.6%) 12743 (50.5%) Reference
OR PEX 14 (7.6%) 1939 (7.7%) 0.82 0.42 1.62 0.572
170 (92.4%) 23298 (92.3%) Reference
OR Age 76.5 (50.0, 91.0) 76.0 (50.0, 100.0) 1.00 0.99 1.02 0.784
OR Duration of surgery 12.6 (5.1, 30.0) 11.1 (3.0, 30.0) 1.04 1.02 1.07 0.002

Abbreviations: CI: confidence interval, F: female, LE: left eye, M: male, OR: odds ratio, pCME: pseudophakic cystoid macular edema, PEX: pseudo exfoliation syndrome, RE: right eye, vs: versus.

Fig 1 shows the probability for a pCME on the y-axis and the running number of cataract surgeries/number of surgeon’s previous cataract surgeries on the x-axis. A B-spline fit shows first a decreasing probability for a pCME with increasing surgeon’s experience within the first 2500 procedures and then an increase after about 4000 performed surgeries.

Fig 1. B-spline fit with three knots; shaded areas, 95% confidence limits.

Fig 1

Between 0 to 10.000 surgeries.

Discussion

In the present study, we analyzed the rate of pCME in association with surgical experience in phacoemulsification and lens implantation.

A learning curve in cataract surgery focusing on posterior capsule ruptures was already reported [24]. This study found a steadily falling rate of posterior capsular ruptures over the first 1500 procedures. In accordance, we found a steady decrease in the rate of pCME according to a surgeon’s expertise, but within the first 2500 procedures.

We observed a significant, 1.58 times higher chance for pCME after uneventful cataract surgery performed by surgeons in training compared to experienced surgeons (95% CI 1.03–2.10, p = 0.034).

Surgeries by surgeons in training were longer (median difference of about 6 minutes) and prolonged duration of surgery was associated with an increased risk for pCME (OR 1.06, 95% CI 1.03–1.09, p<0.001). Recently, Liebmann et al. showed that within the first 39 cases operative time decreased significantly with every additional case by -0.17 minutes, followed by a decrease between the 40 to 149 surgeries by -0.05 minutes with every additional surgery. No further significant improvement in surgery time was observed beyond the 150th cataract surgery [34]. Phacoemulsification time and energy are known to be significantly correlated to visual impairment and development of pCME [35]. Although we could not evaluate effective phacoemulsifications times (EPT), longer duration of surgery possibly correlates to higher EPT and increased manipulation during surgery, being a risk factor for pCME itself.

In our study, surgeons in training more frequently performed cataract surgery on female patients (62.1%) with balanced side distribution (left eyes in 52.0%). However, the overall odds for pCME were lower for female patients (OR 0.77, p = 0.108) and surgeries on left eyes (OR 0.72, p = 0.022).

In Fig 1 we presented a B-spline fit. As illustrated, the rate for pCME steadily declined within the first 2500 surgeries before it flattens at around 3000 surgeries and then slightly increases again at 4000 surgeries until a plateau is reached after 6000 procedures. This configuration of the learning might be attributable to the fact that with increasing experience the probability for pCME decreases. The reason for the increase in the pCME rate among very experienced surgeons might have been caused by the fact that more difficult surgeries are commonly performed by more experienced surgeons. This is in accordance with Böhringer et al. who observed a steadily falling learning curve in the rate of posterior capsular ruptures over the first 1500 procedures, before it leveled off [24].

In our study, no association between PEX and pCME was observed. This is in accordance with observations from Shingleton et al. who found no difference of pCME in bilateral cataract surgery in patients with unilateral PEX [36].

We also analyzed the association between pCME and the surgeon’s sex by additionally including surgeon’s sex in the multivariable model. No association was found (female vs male: OR 1.03, 95% CI 0.72–1.49; p = 0.879). However, ratio of female surgeons is steadily increasing. The sex aspect in medical care is an issue of interest and has further gained importance in recent years. In recent studies by Gupta et al. and Gill et al., intraoperative complications in cataract surgery between female and male surgeons in training did not differ significantly [37, 38]. Hence, the number of women in surgical subspecialities in ophthalmology and the number of procedures completed by women shows disparities as reported by Gill et al. [39] And this is only one gender inequality, besides women in leadership, academics and research, pay gap, harassment, career satisfaction and mentorship. In Canada the number of surgeries performed by male surgeons compared to their female colleagues grew from 1.4 times to 1.7 times between 2000 to 2013. The age at entry is increasing and the percentage of early-career ophthalmologists performing cataract surgery declined [40]. Consenting, further studies reported on the lower cataract surgery volume by women, even after accounting for clinical volume, surgical experience and parental leave [38, 4143].

We therefore encourage the statement by Sharoky et al. that a patient’s surgeons should be selected by experience rather than sex [44].

So far, learning curves in cataract surgery have been discussed frequently. According to previous results, phacoemulsification and capsulorhexis are the highest demanding steps in cataract surgery for residents [20, 45]. The number of intra- and postoperative complications was described to be steadily decreasing with increasing number of previous procedures [34, 4648]. However, Al-Jindan et al. reported that after 40 procedures, proficiency levels were fairly satisfying [20]. Vedana et al. reported that it took 38 cataract surgeries until competency was achieved, assessing posterior capsule ruptures and best corrected visual acuity [21]. In contrast, Taravella et al. proposed an experience of 75 procedures until surgery is performed in a reasonable time without intervention or complication [22]. In accordance, Randleman et al. reported a significant reduction in vitreous loss and phacoemulsification time after the first 80 procedures [23]. However, we do not consent on the conclusion that 40 to 80 previous procedures are enough for a proficient cataract surgery. These numbers should rather be seen as a recommendation before supervision can be eased. As the results by Böhringer et al. and our results could show, learning curves are still ascending and complications rates still declining even after the number of 1000 previous procedures is exceeded [24].

During the study period between January 2010 and September 2018, the standardized postoperative therapeutic regimen consisted of glucocorticoids and antibiotics. However, no non-steroidal anti-inflammatory drugs (NSAIDs) were routinely given before October 2018 at our department. As it could be shown that the use of NSAIDs can prevent the occurrence of pCME after cataract surgery in nondiabetic patients [49], this might have influenced the occurrence of pCME in our study cohort. However, the postoperative therapeutic regimen was the same for both groups and should therefore impact both groups likewise. All patients with diabetes mellitus with and without any kind of diabetic retinopathy, known to have an increased risk for pCME, were excluded from this study.

This study has some limitations. We could only include patients with pCME who were either referred to our department or presented themselves with deteriorated vision or metamorphopsies. However, it concerns surgeries by surgeons in training and experienced surgeons similarly, we therefore assume that this does not influence our results. The Department of Ophthalmology, Medical University of Graz, where this study was conducted is a tertiary care center with a large catchment area. It is therefore assumable that patients with pCME are referred to our department. There are no data on visual acuity pre- and postoperatively. However, the aim of this study was not to compare visual outcomes between groups but to compare rates of postoperative pCME between surgeons in training and experienced surgeons.

In conclusion, the chance of pCME is significantly higher for surgeons in training but steadily decreasing within the first 2500 procedures, also associated to surgical time. No influence on the rate for pCME was found by comparing surgeon’s sex.

Supporting information

S1 Table. Results for multivariable logistic regression (generalized estimating equations model), excluding the first 100 procedures for surgeons in training.

Abbreviations: CI: confidence interval, F: female, LE: left eye, M: male, OR: odds ratio, pCME: pseudophakic cystoid macular edema, PEX: pseudo exfoliation syndrome, RE: right eye, vs: versus.

(DOCX)

Data Availability

Data cannot be shared publicly because data contain potentially identifying or sensitive patient information and restrictions are imposed by the institutional review board. Data are available from the Research Center of the Department of Ophthalmology, Medical University of Graz (Tel.: +4338512394, mail: augwww@medunigraz.at) for researchers who meet the criteria for access to confidential data.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Ray S, D’Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol. 2002;17(3–4):167–80. [PubMed] [Google Scholar]
  • 2.Yonekawa Y, Kim IK. Pseudophakic cystoid macular edema. Curr Opin Ophthalmol. 2012;23(1):26–32. doi: 10.1097/ICU.0b013e32834cd5f8 [DOI] [PubMed] [Google Scholar]
  • 3.Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg. 2007;33(9):1550–8. doi: 10.1016/j.jcrs.2007.05.013 [DOI] [PubMed] [Google Scholar]
  • 4.Loewenstein A, Zur D. Postsurgical cystoid macular edema. Dev Ophthalmol. 2010;47:148–59. doi: 10.1159/000320078 [DOI] [PubMed] [Google Scholar]
  • 5.Cagini C, Fiore T, Iaccheri B, Piccinelli F, Ricci MA, Fruttini D. Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery. Curr Eye Res. 2009;34(12):1036–41. doi: 10.3109/02713680903288937 [DOI] [PubMed] [Google Scholar]
  • 6.Biro Z, Balla Z, Kovacs B. Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye (Lond). 2008;22(1):8–12. doi: 10.1038/sj.eye.6702460 [DOI] [PubMed] [Google Scholar]
  • 7.Ivastinovic D, Schwab C, Mossbock G, Weger M, Possl SL, Petrovski G, et al. The configuration of the vitreomacular interface determines the pattern of pseudophakic cystoid macular oedema. Acta Ophthalmol. 2017;95(4):e347–e8. doi: 10.1111/aos.13104 [DOI] [PubMed] [Google Scholar]
  • 8.Oh JH, Chuck RS, Do JR, Park CY. Vitreous hyper-reflective dots in optical coherence tomography and cystoid macular edema after uneventful phacoemulsification surgery. PLoS One. 2014;9(4):e95066. doi: 10.1371/journal.pone.0095066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Benitah NR, Arroyo JG. Pseudophakic cystoid macular edema. Int Ophthalmol Clin. 2010;50(1):139–53. doi: 10.1097/IIO.0b013e3181c551da [DOI] [PubMed] [Google Scholar]
  • 10.Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36(5):599–619. doi: 10.1016/0002-9394(53)90302-x [DOI] [PubMed] [Google Scholar]
  • 11.Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557–634. [PMC free article] [PubMed] [Google Scholar]
  • 12.Miyake K. [Prostaglandins levels in the aqueous of vitreous tug syndrome and their changes by pars plana vitrectomy (author’s transl)]. Nippon Ganka Gakkai Zasshi. 1980;84(10):1461–7. [PubMed] [Google Scholar]
  • 13.Kremer M, Baikoff G, Charbonnel B. The release of prostaglandins in human aqueous humour following intraocular surgery. Effect of indomethacin. Prostaglandins. 1982;23(5):695–702. doi: 10.1016/s0090-6980(82)80007-5 [DOI] [PubMed] [Google Scholar]
  • 14.Thomas MA, O’Grady GE, Swartz SL. Prostaglandin levels in human vitreous. Br J Ophthalmol. 1985;69(4):275–9. doi: 10.1136/bjo.69.4.275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Schepens CL, Avila MP, Jalkh AE, Trempe CL. Role of the vitreous in cystoid macular edema. Surv Ophthalmol. 1984;28 Suppl:499–504. doi: 10.1016/0039-6257(84)90232-7 [DOI] [PubMed] [Google Scholar]
  • 16.Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999;25(11):1492–7. doi: 10.1016/s0886-3350(99)00196-0 [DOI] [PubMed] [Google Scholar]
  • 17.Xu H, Chen M, Forrester JV, Lois N. Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion. Invest Ophthalmol Vis Sci. 2011;52(1):249–55. doi: 10.1167/iovs.10-6001 [DOI] [PubMed] [Google Scholar]
  • 18.Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47 Suppl 1:S203–18. [DOI] [PubMed] [Google Scholar]
  • 19.Kaplowitz K, Yazdanie M, Abazari A. A review of teaching methods and outcomes of resident phacoemulsification. Surv Ophthalmol. 2018;63(2):257–67. doi: 10.1016/j.survophthal.2017.09.006 [DOI] [PubMed] [Google Scholar]
  • 20.Al-Jindan M, Almarshood A, Yassin SA, Alarfaj K, Al Mahmood A, Sulaimani NM. Assessment of Learning Curve in Phacoemulsification Surgery Among the Eastern Province Ophthalmology Program Residents. Clin Ophthalmol. 2020;14:113–8. doi: 10.2147/OPTH.S241250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vedana G, Cardoso FG, Marcon AS, Araujo LEK, Zanon M, Birriel DC, et al. Cumulative sum analysis score and phacoemulsification competency learning curve. Int J Ophthalmol. 2017;10(7):1088–93. doi: 10.18240/ijo.2017.07.11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Taravella MJ, Davidson R, Erlanger M, Guiton G, Gregory D. Characterizing the learning curve in phacoemulsification. J Cataract Refract Surg. 2011;37(6):1069–75. doi: 10.1016/j.jcrs.2010.12.054 [DOI] [PubMed] [Google Scholar]
  • 23.Randleman JB, Wolfe JD, Woodward M, Lynn MJ, Cherwek DH, Srivastava SK. The resident surgeon phacoemulsification learning curve. Arch Ophthalmol. 2007;125(9):1215–9. doi: 10.1001/archopht.125.9.1215 [DOI] [PubMed] [Google Scholar]
  • 24.Bohringer D, Vach W, Hagenlocher K, Eberwein P, Maier P, Reinhard T. Are entry criteria for cataract surgery justified? PLoS One. 2014;9(11):e112819. doi: 10.1371/journal.pone.0112819 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC, et al. Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. Ophthalmology. 2016;123(2):316–23. doi: 10.1016/j.ophtha.2015.10.001 [DOI] [PubMed] [Google Scholar]
  • 26.Law SK, Kim E, Yu F, Caprioli J. Clinical cystoid macular edema after cataract surgery in glaucoma patients. J Glaucoma. 2010;19(2):100–4. [PubMed] [Google Scholar]
  • 27.Trinavarat A, Neerucha V. Visual outcome after cataract surgery complicated by posterior capsule rupture. J Med Assoc Thai. 2012;95 Suppl 4:S30–5. [PubMed] [Google Scholar]
  • 28.Han JV, Patel DV, Squirrell D, McGhee CN. Cystoid macular oedema following cataract surgery: A review. Clin Exp Ophthalmol. 2019;47(3):346–56. doi: 10.1111/ceo.13513 [DOI] [PubMed] [Google Scholar]
  • 29.Healy R, Buscombe C, Chu CJ, Mohamed Q, Sallam AAI, Johnston R. The incidence of cystoid macular edema after cataract surgery and the effect of posterior capsule rupture. Investigative Ophthalmology & Visual Science. 2015;56(7):670-. [Google Scholar]
  • 30.Kim SJ, Bressler NM. Optical coherence tomography and cataract surgery. Curr Opin Ophthalmol. 2009;20(1):46–51. doi: 10.1097/icu.0b013e3283199162 [DOI] [PubMed] [Google Scholar]
  • 31.Seidel G, Hausberger S, Herzog SA, Palkovits S, Poschl EM, Wackernagel W, et al. Circadian macular volume changes in the healthy human choroid. Am J Ophthalmol. 2015;159(2):365–71 e2. doi: 10.1016/j.ajo.2014.11.002 [DOI] [PubMed] [Google Scholar]
  • 32.Seidel G, Aschinger G, Singer C, Herzog SA, Weger M, Haas A, et al. Estimating Retinal Blood Flow Velocities by Optical Coherence Tomography. JAMA Ophthalmol. 2016;134(10):1104–10. doi: 10.1001/jamaophthalmol.2016.2507 [DOI] [PubMed] [Google Scholar]
  • 33.Ying GS, Maguire MG, Glynn R, Rosner B. Tutorial on Biostatistics: Statistical Analysis for Correlated Binary Eye Data. Ophthalmic Epidemiol. 2018;25(1):1–12. doi: 10.1080/09286586.2017.1320413 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Liebman DL, McKay KM, Haviland MJ, Moustafa GA, Borkar DS, Kloek CE. Quantifying the educational benefit of additional cataract surgery cases in ophthalmology residency. J Cataract Refract Surg. 2020;46(11):1495–500. doi: 10.1097/j.jcrs.0000000000000298 [DOI] [PubMed] [Google Scholar]
  • 35.Ferrari TM, Cavallo M, Durante G, Mininno L, Cardascia N. Macular edema induced by phacoemulsification. Doc Ophthalmol. 1999;97(3–4):325–7. doi: 10.1023/a:1002142307952 [DOI] [PubMed] [Google Scholar]
  • 36.Shingleton BJ, Nguyen BK, Eagan EF, Nagao K, O’Donoghue MW. Outcomes of phacoemulsification in fellow eyes of patients with unilateral pseudoexfoliation: single-surgeon series. J Cataract Refract Surg. 2008;34(2):274–9. doi: 10.1016/j.jcrs.2007.09.040 [DOI] [PubMed] [Google Scholar]
  • 37.Gupta S, Haripriya A, Ravindran RD, Ravilla T. Differences Between Male and Female Residents in Case Volumes and Learning in Cataract Surgery. J Surg Educ. 2021;78(4):1366–75. doi: 10.1016/j.jsurg.2020.12.017 [DOI] [PubMed] [Google Scholar]
  • 38.Gill HK, Niederer RL, Danesh-Meyer HV. Gender differences in surgical case volume among ophthalmology trainees. Clin Exp Ophthalmol. 2021;49(7):664–71. doi: 10.1111/ceo.13969 [DOI] [PubMed] [Google Scholar]
  • 39.Gill HK, Niederer RL, Shriver EM, Gordon LK, Coleman AL, Danesh-Meyer HV. An Eye on Gender Equality: A Review of the Evolving Role and Representation of Women in Ophthalmology. Am J Ophthalmol. 2022;236:232–40. doi: 10.1016/j.ajo.2021.07.006 [DOI] [PubMed] [Google Scholar]
  • 40.Micieli JA, Trope GE, Buys YM. Gender gap and declining surgical activity among new graduates: cataract surgery in Ontario. Can J Ophthalmol. 2016;51(3):154–60. doi: 10.1016/j.jcjo.2016.04.013 [DOI] [PubMed] [Google Scholar]
  • 41.Feng PW, Ahluwalia A, Adelman RA, Chow JH. Gender Differences in Surgical Volume among Cataract Surgeons. Ophthalmology. 2021;128(5):795–6. doi: 10.1016/j.ophtha.2020.09.031 [DOI] [PubMed] [Google Scholar]
  • 42.Gong D, Winn BJ, Beal CJ, Blomquist PH, Chen RW, Culican SM, et al. Gender Differences in Case Volume Among Ophthalmology Residents. JAMA Ophthalmol. 2019;137(9):1015–20. doi: 10.1001/jamaophthalmol.2019.2427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.French DD, Margo CE, Campbell RR, Greenberg PB. Volume of Cataract Surgery and Surgeon Gender: The Florida Ambulatory Surgery Center Experience 2005 Through 2012. J Med Pract Manage. 2016;31(5):297–302. [PubMed] [Google Scholar]
  • 44.Sharoky CE, Sellers MM, Keele LJ, Wirtalla CJ, Karakousis GC, Morris JB, et al. Does Surgeon Sex Matter?: Practice Patterns and Outcomes of Female and Male Surgeons. Ann Surg. 2018;267(6):1069–76. doi: 10.1097/SLA.0000000000002460 [DOI] [PubMed] [Google Scholar]
  • 45.Dooley IJ, O’Brien PD. Subjective difficulty of each stage of phacoemulsification cataract surgery performed by basic surgical trainees. J Cataract Refract Surg. 2006;32(4):604–8. doi: 10.1016/j.jcrs.2006.01.045 [DOI] [PubMed] [Google Scholar]
  • 46.Umali MIN, Castillo TR. Operative Time and Complication Rates of Resident Phacoemulsification Surgeries in a National University Hospital: A Five-Year Review. Clin Ophthalmol. 2020;14:4065–72. doi: 10.2147/OPTH.S283754 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Mangan MS, Atalay E, Arici C, Tuncer I, Bilgec MD. Comparison of Different Types of Complications in the Phacoemulsification Surgery Learning Curve According to Number of Operations Performed. Turk J Ophthalmol. 2016;46(1):7–10. doi: 10.4274/tjo.83788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Aaronson A, Viljanen A, Kanclerz P, Grzybowski A, Tuuminen R. Cataract complications study: an analysis of adverse effects among 14,520 eyes in relation to surgical experience. Ann Transl Med. 2020;8(22):1541. doi: 10.21037/atm-20-845 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wielders LHP, Schouten J, Winkens B, van den Biggelaar F, Veldhuizen CA, Findl O, et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg. 2018;44(4):429–39. doi: 10.1016/j.jcrs.2018.01.029 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Andrzej Grzybowski

19 Jul 2022

PONE-D-22-14684The Impact of Surgeon’s Experience and Sex on the Incidence of Cystoid Macular Edema after uneventful Cataract SurgeryPLOS ONE

Dear Dr. List,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 02 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Andrzej Grzybowski

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. You indicated that ethical approval was not necessary for your study. We understand that the framework for ethical oversight requirements for studies of this type may differ depending on the setting and we would appreciate some further clarification regarding your research. Could you please provide further details on why your study is exempt from the need for approval and confirmation from your institutional review board or research ethics committee (e.g., in the form of a letter or email correspondence) that ethics review was not necessary for this study? Please include a copy of the correspondence as an "Other" file.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: this interesting manuscript demonstrated that the surgeon's little experience increases the chance of cystoid macular edema in cataract surgery with intraocular lens implantation.

The segmented analysis of surgeons with more than 100 surgeries further reinforced this thesis

Reviewer #2: This paper is quite ambitious in its goal because of the large number of parameters included to evaluate the risk of pCME after cataract surgery performed by trainees versus experienced surgeons. Most readers will start with a guess that indeed they indeed expect to have higher pCME in trainees compared to experienced surgeons. This is also the conclusion of the authors.

However, this paper would still have been of interest provided the study parameters studied were precisely defined.

The idea is to study pCME (psuedophakic CME), however, the chapter on materials and methods does not define when the OCT of the macula was performed and whether this was performed systematically. It becomes clear for the reader when reading the discussion (page 17 line320-322) that pCME has not been studied as such but clinically significant CME has been studied. Patients were referred when presenting visual complaints and when the visual disturbances could be objectivated by means of OCT images.

This is a major point that needs to be clearly stated form the start.

Page 4 line 73: the numbers 2.61 to 5.05 are ODDS ratios?

Page 6 line 104: surgical time is not defined. starting point-end point? Phako time? Please specify

Page 7 line 109: We do understand it is a retrospective study, needing approval of the Ethical committee but without the need for signed patient's informed consent. I suppose this is what the authors wanted to explain in their paper?

Page 7 line 127: There is no clear-cut definition of which surgeon is considered trainee or experienced surgeon. A trainee is per definition an MD who is in training to become ophthalmologist. However, the reader gets the impression that the authors consider a trainee somebody who is already ophthalmologist but in training to become senior cataract surgeon. I think the authors mix the terms of trainee, fellow and sub-specialist in cataract and refractive surgeon. It would have been much clearer if the authors would have considered clear differences in the two surgeon groups studied. This remains a very week point.

Page 9 line 172-174: Is PEX an indication for trainees?

Page 11 line 206: babies are also included in the case series (age ranging from 0- 100) of experienced surgeons. babies, children and young adults should have been excluded from this study

Page 15 line 277-289: the surgeon's sex discussion from the literature is inappropriately related to ophthalmology.

Reviewer #3: The authors retrospectively compared rate of CME after cataract surgery between surgeons of different sex and experience. The drawback is related to retrospective nature of the study. As you have not performed OCT, you can not say how many patients have CME. You can just say that from those patients that had related complaints, 188 patients had CME.

The second draw back is entering both eyes of some patients and one eye of some patients that make inter-eye correlation study necessary that you have not performed.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: RODRIGO PESSOA CAVALCANTI LIRA

Reviewer #2: No

Reviewer #3: Yes: Hesam Hashemian

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 27;17(12):e0279518. doi: 10.1371/journal.pone.0279518.r002

Author response to Decision Letter 0


23 Oct 2022

Dear Prof. Grzybowski, MD, PhD, MBA!

thank you very much for the thorough review of our manuscript and giving us the opportunity to make corrections according to the valuable recommendations of the reviewers. Three reviewers have carefully examined our paper, raising points that help us to improve our manuscript as it is currently present.

PLOS ONE would be a most optimal venue to communicate our findings to the global audience in clinical science.

The corrections we made in the paper are listed below. The corrections are highlighted in the marked-up copy version of the manuscript.

We also implemented the journal requirements. The manuscript now meets PLOS ONE’s style requirements. Ethical approval is given for the study and stated in the manuscript. The Ethics Committee of the Medical University of Graz ruled that written informed consent was not required for this study from each participant. All relevant data are presented in the manuscript. Patient-level data contain potentially sensitive information and are not publicly available in a repository due to restrictions based upon privacy and ethical regulations.

***************************************************************************

Reviewer #1

Reviewer #1 writes: “This interesting manuscript demonstrated that the surgeon's little experience increases the chance of cystoid macular edema in cataract surgery with intraocular lens implantation. The segmented analysis of surgeons with more than 100 surgeries further reinforced this thesis”

Author response:

We thank the reviewer for this comment on our manuscript.

Reviewer #2 writes: “This paper is quite ambitious in its goal because of the large number of parameters included to evaluate the risk of pCME after cataract surgery performed by trainees versus experienced surgeons. Most readers will start with a guess that indeed they expect to have higher pCME in trainees compared to experienced surgeons. This is also the conclusion of the authors.

However, this paper would still have been of interest provided the study parameters studied were precisely defined.

The idea is to study pCME (psuedophakic CME), however, the chapter on materials and methods does not define when the OCT of the macula was performed and whether this was performed systematically. It becomes clear for the reader when reading the discussion (page 17 line320-322) that pCME has not been studied as such but clinically significant CME has been studied. Patients were referred when presenting visual complaints and when the visual disturbances could be objectivated by means of OCT images.

This is a major point that needs to be clearly stated form the start.”

Author response:

We thank the reviewer for reviewing our manuscript and the very important comments to improve this study! With this response, we hope to implement your recommendations and your experience into our manuscript.

Due to the retrospective nature of the study and the standardized postoperative management we were not able to perform OCT scans on every patient at predefined follow-ups. After discharge from the hospital on the day of surgery patients are referred to a postoperative examination at a registered ophthalmologist within two to five days. However, patients with persisting cystoid macular edema or visual deterioration are usually referred to our acute day ward, where OCT scans of the macula and if required fluorescein- and indocyanine green angiographies are performed. Although not all postoperative CME will be screened with this approach, we assume that the loss of diagnosed patients will affect both study groups in the same manner.

Spectral domain OCTs (Heidelberg Engineering, Heidelberg, Germany were conducted using volume scanning with 25 sections covering a field of 20x20° in the macular region. A built-in eye tracking software ensured exact position of the recorded scans. Sections were received using the high-speed mode with a resolution of 7 μm axially x 14μm laterally and a distance of 240 μm between sections. CME was defined as macular thickness >300 μm and the presence of intraretinal hyporeflective cysts within the ETDRS (Early Treatment Diabetic Retinopathy Study) circle.

This information was provided in the methods section of the manuscript.

Reviewer #2 writes: “Page 4 line 73: the numbers 2.61 to 5.05 are ODDS ratios?”

Author response:

The numbers 2.61 to 5.05 declare an increase of the relative risk. This missing information was added to the corresponding lines.

Reviewer #2 writes: “Page 6 line 104: surgical time is not defined. starting point-end point? Phako time? Please specify”

Author response:

The surgical time is defined as the time difference from the beginning of the surgery (first incision of the cornea) until the end of the surgery (after intracameral injection of cefuroxime). This was added to the corresponding line in the manuscript.

Reviewer #2 writes: “Page 7 line 109: We do understand it is a retrospective study, needing approval of the Ethical committee but without the need for signed patient's informed consent. I suppose this is what the authors wanted to explain in their paper?”

Author response:

Thank you very much for this correction. We certainly obtained approval from the local ethical committee, but waiver was given for the necessity for written informed consent.

Reviewer #2 writes: “Page 7 line 127: There is no clear-cut definition of which surgeon is considered trainee or experienced surgeon. A trainee is per definition an MD who is in training to become ophthalmologist. However, the reader gets the impression that the authors consider a trainee somebody who is already ophthalmologist but in training to become senior cataract surgeon. I think the authors mix the terms of trainee, fellow and sub-specialist in cataract and refractive surgeon. It would have been much clearer if the authors would have considered clear differences in the two surgeon groups studied. This remains a very week point.”

Author response:

According to a previous study by Böhringer et al. we defined a cut-off for “unexperienced” surgeons named as surgeons in training or trainees and “experienced” surgeons at 300 surgeries. The German Ophthalmological Society recommended that the first 300 cataract surgeries should be done under supervision before enough experience is acquired. We analyzed this threshold for the occurrence of pCME. The terms “trainee” and “experienced surgeon” therefore do not represent the level of medical training but surgical experience. Surgeries by “trainees” in our manuscript corresponds to a “training surgery” by Böhringer et al. This obscurity was clarified in the manuscript. The term “trainee” was changed to “surgeon in training” in the manuscript.

Reviewer #2 writes: “Page 9 line 172-174: Is PEX an indication for trainees?”

Author response:

The presence of pseudo exfoliation syndrome was documented for every surgery in both groups and analyzed as a risk factor for pCME. Trainees and experienced surgeons were doing the surgeries on patients with PEX.

Reviewer #2 writes: “Page 11 line 206: babies are also included in the case series (age ranging from 0- 100) of experienced surgeons. babies, children and young adults should have been excluded from this study”

Author response:

Thank you very much for this remark. It is of course not intended to include babies, children, and young adults but only patients with senile cataracts. We therefore changed the inclusion criteria to patient’s age ranging from 50 years to 100 years.

Reviewer #2 writes: “Page 15 line 277-289: the surgeon's sex discussion from the literature is inappropriately related to ophthalmology.”

Author response:

The discussion on gender in cataract surgery volume and complication rates was changed. Recent and relevant literature was included and the discussion on complications in specialties other than ophthalmology was removed.

Reviewer #3 writes: “The authors retrospectively compared rate of CME after cataract surgery between surgeons of different sex and experience. The drawback is related to retrospective nature of the study. As you have not performed OCT, you can not say how many patients have CME. You can just say that from those patients that had related complaints, 188 patients had CME.”

Author response:

Thank you for this remark. Duo to the retrospective design of the study and aim of the study we did not perform standardized OCT of the macula for every patient. We therefore only report on clinically significant edema of patients who were referred to our clinics. Hence, the number of patients with pCME does not describe an incidence. We changed the sentence “In total, pCME occurred in 188 eyes …” to “In total, pCME was reported in 188 eyes …”.

Reviewer #3 writes: “The second draw back is entering both eyes of some patients and one eye of some patients that make inter-eye correlation study necessary that you have not performed.”

Author response:

To account for inter-eye correlation in the data, Generalized Estimating Equation (GEE) models with exchangeable working correlation structure were used. This approach is suggested by Ying et al (PMID: 28532207). However, including only one eye per patient (the first documented eye) yields similar results (table below). The reference was changed in the materials and methods section and the information was added in the results section.

Attachment

Submitted filename: Response to the Reviewers.docx

Decision Letter 1

Andrzej Grzybowski

8 Dec 2022

The Impact of Surgeon’s Experience and Sex on the Incidence of Cystoid Macular Edema after uneventful Cataract Surgery

PONE-D-22-14684R1

Dear Dr. List,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Andrzej Grzybowski

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for preparing a good revision.

Reviewers' comments: 

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: The main drawback as mentioned in the first review is the weak retrospective design and failure to document cases of CME with OCT.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

**********

Acceptance letter

Andrzej Grzybowski

15 Dec 2022

PONE-D-22-14684R1

The impact of surgeon’s experience and sex on the incidence of cystoid macular edema after uneventful cataract surgery

Dear Dr. List:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Andrzej Grzybowski

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Results for multivariable logistic regression (generalized estimating equations model), excluding the first 100 procedures for surgeons in training.

    Abbreviations: CI: confidence interval, F: female, LE: left eye, M: male, OR: odds ratio, pCME: pseudophakic cystoid macular edema, PEX: pseudo exfoliation syndrome, RE: right eye, vs: versus.

    (DOCX)

    Attachment

    Submitted filename: Response to the Reviewers.docx

    Data Availability Statement

    Data cannot be shared publicly because data contain potentially identifying or sensitive patient information and restrictions are imposed by the institutional review board. Data are available from the Research Center of the Department of Ophthalmology, Medical University of Graz (Tel.: +4338512394, mail: augwww@medunigraz.at) for researchers who meet the criteria for access to confidential data.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES